AGER-dependent macropinocytosis drives resistance to KRAS-G12D–targeted therapy in advanced pancreatic cancer

克拉斯 胰腺癌 医学 癌症 癌症研究 胞饮病 靶向治疗 内科学 肿瘤科 结直肠癌 内吞作用 受体
作者
Changfeng Li,Yuanda Liu,Chang Liu,Fangquan Chen,Yangchun Xie,Herbert J. Zeh,Chunhua Yu,Jiao Liu,Daolin Tang,Rui Kang
出处
期刊:Science Translational Medicine [American Association for the Advancement of Science]
卷期号:17 (783): eadp4986-eadp4986 被引量:36
标识
DOI:10.1126/scitranslmed.adp4986
摘要

Pancreatic ductal adenocarcinoma (PDAC) driven by the KRAS-G12D mutation presents a formidable health challenge because of limited treatment options. MRTX1133 is a highly selective and first-in-class KRAS-G12D inhibitor under clinical development. Here, we report that the advanced glycosylation end product–specific receptor (AGER) plays a key role in mediating MRTX1133 resistance in PDAC cells. The up-regulation of AGER within cancer cells instigates macropinocytosis, facilitating the internalization of serum albumin and subsequent amino acid generation. These amino acids are then used to synthesize the antioxidant glutathione, leading to resistance to MRTX1133 treatment due to the inhibition of apoptosis. The underlying molecular mechanism involves AGER’s interaction with diaphanous-related formin 1 (DIAPH1), a formin protein responsible for driving Rac family small GTPase 1 (RAC1)–dependent macropinosome formation. The effectiveness and safety of combining MRTX1133 with pharmacological inhibitors of the AGER-DIAPH1 complex (using RAGE299) or macropinocytosis (using EIPA) were confirmed in patient-derived xenografts, orthotopic models, and genetically engineered mouse PDAC models. This combination therapy also induces high-mobility group box 1 (HMGB1) release, resulting in a subsequent antitumor CD8 + T cell response in immunocompetent mice. Collectively, the study findings underscore the potential to enhance the efficacy of KRAS-G12D blockade therapy by targeting AGER-dependent macropinocytosis.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
zhazhao发布了新的文献求助10
刚刚
华仔的应助被serein采纳,获得10
刚刚
刚刚
刚刚
刚刚
只要一点点的应助被舒心易烟采纳,获得10
1秒前
科研通AI65的应助被Mmxn采纳,获得10
1秒前
1秒前
2秒前
2秒前
Teletubbies的应助被Gally采纳,获得20
2秒前
田様的应助被zhangyaoyang采纳,获得10
3秒前
甜甜圈发布了新的文献求助10
3秒前
江北小赵发布了新的文献求助10
3秒前
4秒前
you完成签到,获得积分10
4秒前
4秒前
Sheng完成签到,获得积分10
4秒前
Ava的应助被初景采纳,获得10
5秒前
zhc发布了新的文献求助10
5秒前
5秒前
ZYK完成签到,获得积分10
5秒前
踏实的弼完成签到,获得积分10
6秒前
wei发布了新的文献求助10
6秒前
科目三的应助被甜瓜甜采纳,获得10
6秒前
6秒前
深情安青的应助被陈欣怡采纳,获得10
6秒前
M3L2发布了新的文献求助10
6秒前
汉堡包的应助被欧文采纳,获得10
6秒前
天天快乐的应助被霁月采纳,获得10
6秒前
李健的小迷弟的应助被霁月采纳,获得10
7秒前
汉堡包的应助被霁月采纳,获得10
7秒前
斯文败类的应助被霁月采纳,获得10
7秒前
HWB发布了新的文献求助10
7秒前
Antirick发布了新的文献求助10
7秒前
天天快乐的应助被小鱼采纳,获得10
8秒前
8秒前
板蓝根完成签到,获得积分10
8秒前
收声发布了新的文献求助200
8秒前
科研通AI6.3的应助被牧百川采纳,获得10
9秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8183046
求助须知:如何正确求助?哪些是违规求助? 9572370
关于积分的说明 21824411
捐赠科研通 7779694
什么是DOI,文献DOI怎么找? 3433792
关于科研通互助平台的介绍 2558024
邀请新用户注册赠送积分活动 2479971